½ÃÀ庸°í¼­
»óǰÄÚµå
1580997

¼¼°èÀÇ ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå : Á¦Ç°, Åõ¿© ¹æ¹ý, ¸ðµå, Á¶ÀÛ, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, À¯Åë ä³Îº° ¿¹Ãø(2025-2030³â)

Infusion Pumps & Accessories Market by Product (Accessories & Consumables, Infusion Pumps), Mode of Administration (Arterial, Epidural, Intravenous), Mode, Operation, Application, End-User, Distribution Channel - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 196 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀåÀº 2023³â¿¡ 165¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 178¾ï 3,000¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.84%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 281¾ï 1,000¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸®´Â °Ç°­ °ü¸® ºÐ¾ß¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, ¾à¹°À̳ª ¿µ¾ç¼Ò¿Í °°Àº ÁÖÀÔÀ» ȯÀÚÀÇ Ã¼³»·Î Á¦¾îµÇ´Â ¾ç¸¸Å­ Àü´ÞÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ½ÃÀå ¹üÀ§¿¡´Â ¿ë·® ÆßÇÁ, ÁÖ»ç±â ÆßÇÁ, ȯÀÚ Á¦¾î ÁøÅë ÆßÇÁ¿Í °°Àº ´Ù¾çÇÑ À¯ÇüÀÇ ÆßÇÁ¿Í Æ©ºê, Ä«Å×ÅÍ, Ư¼ö µå¸³ ¼¼Æ® µî ÇÊ¿äÇÑ ¾×¼¼¼­¸®°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ Àåºñ´Â º´¿ø, Ŭ¸®´Ð, ÀçÅÃÄ¡·á ÇöÀå¿¡¼­ ¸Å¿ì Áß¿äÇϸç ÅëÁõ °ü¸®, ´ç´¢º´ °ü¸®, È­ÇÐ ¿ä¹ý µîÀÇ ¸ñÀû¿¡ À¯¿ëÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, ÀÇ·á±â±âÀÇ ±â¼ú Áøº¸, ÀçÅà Çコ ÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿äÀÎÀÇ ¿µÇâÀ» ¹Þ¾Æ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ COVID-19ÀÇ ´ëÀ¯ÇàÀº ¾ÈÁ¤ÀûÀÌ°í ´ÙÀç´Ù´ÉÇÑ ÀÇ·á±â±âÀÇ Çʿ伺À» °­Á¶ÇÏ°í ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ½º¸¶Æ® ÁÖÀÔ ½Ã½ºÅÛÀÇ °íºñ¿ë, Àåºñ ¿ÀÀÛµ¿ À§Çè µî°ú °°Àº °úÁ¦°¡ ÀáÀçÀûÀÎ ¹ßÆÇÀÌ µÇ°í ÀÖ½À´Ï´Ù. ºñ¿ë È¿À²ÀûÀ̰í È޴뼺ÀÌ ¶Ù¾î³ª°í »ç¿ëÇϱ⠽¬¿î ÆßÇÁÀÇ °³¹ß µî ÀÌ·¯ÇÑ °úÁ¦¸¦ ÇØ°áÇÏ´Â °ÍÀ̾߸»·Î ±âȸ°¡ ÀÖ½À´Ï´Ù. ¹«¼± ¿¬°á°ú °Ç°­ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°úÀÇ ÅëÇÕ¿¡ °üÇÑ Á¶»ç´Â ÁÖÀÔ ½Ã½ºÅÛÀÇ ±â´É°ú ¸Å·ÂÀ» º¯È­½Ãų ¼ö ÀÖ´Â °­·ÂÇÑ ±â¼ú Çõ½Å ºÐ¾ßÀÔ´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚÀÇ ¿ä±¸¿¡ ¸Â´Â ¼Ö·ç¼ÇÀ» Á¦°øÇϱâ À§ÇØ °Ç°­ °ü¸® Á¦°ø¾÷ü¿Í Çù·ÂÇÏ´Â °Íµµ Àü·«Àû ÀÏ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀº Ä¡¿­ÇÏ°í ±ÔÁ¦°¡ ¸¹±â ¶§¹®¿¡ Áö¼ÓÀûÀÎ Çõ½Å°ú ÀûÀÀ¼ºÀÌ ¿ä±¸µË´Ï´Ù. ±â¾÷Àº µ¥ÀÌÅÍ ºÐ¼®À» Ȱ¿ëÇÏ¿© Á¦Ç° Á¦°øÀ» Á¤±³ÇÏ°Ô ¸¸µé°í ¼ö¿ä°¡ ÃæºÐÈ÷ ÃæÁ·µÇÁö ¾Ê´õ¶óµµ ºü¸£°Ô ¼ºÀåÇÒ ¼ö ÀÖ´Â ½ÅÈï ½ÃÀå¿¡ ÃÊÁ¡À» ¸ÂÃâ ¼ö ÀÖ½À´Ï´Ù. ÁÖÀÔ ½Ã½ºÅÛ¿¡¼­ AI¿Í IoT ¿ëµµÀ» °Ü³ÉÇÑ Áøº¸´Â ȹ±âÀûÀÎ ¼Ö·ç¼ÇÀ» ¸¸µé¾î »õ·Î¿î °í°´ÃþÀ» È®º¸ÇÏ°í ¾÷°è Ç¥ÁØÀ» ¼¼¿ï ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 165¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 178¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 281¾ï 1,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 7.84%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ëÀ¸·Î º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ´ç´¢º´, ¾Ï, ½ÉÇ÷°ü Áúȯ µîÀÇ ¸¸¼º ÁúȯÀÇ À¯º´·üÀÇ »ó½Â
    • ¼ö¾×¿ä¹ý¿¡ ´ëÇÑ À¯¸®ÇÑ ±ÔÁ¦¿Í º¸Çè Àû¿ë
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • °í±Þ ÁÖÀÔ ÆßÇÁÀÇ Ãʱâ ÅõÀÚ¿Í À¯Áö º¸¼ö ºñ¿ëÀÇ ³ôÀÌ
  • ½ÃÀå ±âȸ
    • Åõ¿© Á¤¹Ðµµ Çâ»ó°ú À¯Áö º¸¼ö ¿ä°Ç ¿¹ÃøÀ» À§ÇÑ AI ÅëÇÕ
    • °¨¿° À§ÇèÀ» ÁÙÀ̰í ȯÀÚÀÇ ¾ÈÀü¼ºÀ» Çâ»ó½Ã۱â À§ÇÑ º¸´Ù »ýüÀûÇÕ¼ºÀÌ ³ôÀº Àç·áÀÇ Çõ½Å
  • ½ÃÀåÀÇ °úÁ¦
    • ÀÇ·á±â±â¿¡ °üÇÑ º¹ÀâÇÑ ±ÔÁ¦ ȯ°æ¿¡ ´ëÀÀÇÏ´Â °ÍÀ¸·Î, Á¦Ç° Ãâ½Ã°¡ Áö¿¬µÉ °¡´É¼º

Porter's Five Forces : ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ´ç´¢º´, ¾Ï, ½ÉÇ÷°ü Áúȯ µîÀÇ ¸¸¼º ÁúȯÀÇ ÀÌȯÀ²ÀÇ »ó½Â
      • ¼ö¾×¿ä¹ý¿¡ ´ëÇÑ À¯¸®ÇÑ ±ÔÁ¦¿Í º¸Çè Àû¿ë
    • ¾ïÁ¦¿äÀÎ
      • °í±Þ ÁÖÀÔ ÆßÇÁÀÇ Ãʱâ ÅõÀÚ¿Í À¯Áö º¸¼ö ºñ¿ëÀÌ ³ô½À´Ï´Ù
    • ±âȸ
      • AI¸¦ ÅëÇÕÇÏ¿© Åõ¿© Á¤¹Ðµµ¸¦ Çâ»ó½ÃÄÑ, À¯Áö º¸¼öÀÇ Çʿ伺À» ¿¹ÃøÇÑ´Ù
      • °¨¿° À§ÇèÀ» ÁÙÀ̰í ȯÀÚÀÇ ¾ÈÀü¼ºÀ» Çâ»ó½ÃŰ´Â º¸´Ù »ýü ÀûÇÕ¼ºÀÌ ³ôÀº Àç·áÀÇ Çõ½Å
    • °úÁ¦
      • ÀÇ·á±â±âÀÇ º¹ÀâÇÑ ±ÔÁ¦ ȯ°æÀ» ±Øº¹ÇÔÀ¸·Î½á, Á¦Ç°ÀÇ ¹ß¸Å°¡ Áö¿¬µÉ °¡´É¼ºÀÌ ÀÖ´Ù
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • Á¦Ç° : ȯÀÚÀÇ ¼øÈ¯°è¿¡ ¾×ü¸¦ ÁÖÀÔÇϱâ À§ÇÑ ÁÖÀÔ ÆßÇÁ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
    • ÃÖÁ¾ »ç¿ëÀÚ : ³ôÀº ½Å·Ú¼º°ú ´Ù¾çÇÑ Ä¡·á¿ÍÀÇ È£È¯¼ºÀ¸·Î º´¿ø ä¿ë Áõ°¡
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå : Á¦Ç°º°

  • ¾×¼¼¼­¸®¿Í ¼Ò¸ðǰ
    • ij´¼¶ó
    • ÁÖÀÔ Ä«Å×ÅÍ
    • IV ¼¼Æ®
    • ´Ïµé¸®½º Ä¿³ØÅÍ
  • ÁÖÀÔ ÆßÇÁ
    • ÈÞ´ëÇü ÁÖÀÔ ÆßÇÁ
    • °æÀå ÁÖÀÔ ÆßÇÁ
    • ¸Å¸³Çü ÁÖÀÔ ÆßÇÁ
    • Àν¶¸° ÁÖÀÔ ÆßÇÁ
    • ȯÀÚ°¡ Á÷Á¢ Á¦¾îÇÏ´Â ÁøÅë ÆßÇÁ
    • ÁÖ»ç±â ÁÖÀÔ ÆßÇÁ
    • ¿ëÀû½Ä ÁÖÀÔ ÆßÇÁ

Á¦7Àå ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå :Åõ¿© ¹æ¹ýº°

  • µ¿¸Æ
  • °æ¸·¿Ü ¸¶Ãë
  • Á¤¸Æ³»
  • ÇÇÇÏ

Á¦8Àå ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå : ¸ðµåº°

  • ÈÞ´ë¿ë ÁÖÀÔ ÆßÇÁ
  • °ÅÄ¡Çü ÁÖÀÔ ÆßÇÁ

Á¦9Àå ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå : Á¶ÀÛº°

  • Àüµ¿½Ä
  • ±â°è Á¶ÀÛ

Á¦10Àå ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå : ¿ëµµº°

  • ÁøÅë/ÅëÁõ °ü¸®
  • È­Çпä¹ý
  • ´ç´¢º´ °ü¸®
  • ¼ÒÈ­±â ³»°ú
  • Ç÷¾×ÇÐ
  • ¼Ò¾Æ°ú, ½Å»ý¾Æ°ú

Á¦11Àå ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Çмú¿¬±¸±â°ü
  • ¿Ü·¡ Áø·á ȯ°æ
  • ȨÄɾî
  • º´¿ø

Á¦12Àå ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå : À¯Åë ä³Îº°

  • ¿ÀÇÁ¶óÀÎ
    • Á÷Á¢ ÆÇ¸Å
    • º´¿ø ¾à±¹
    • ¼Ò¸Å ¾à±¹
  • ¿Â¶óÀÎ

Á¦13Àå ¾Æ¸Þ¸®Ä«ÀÇ ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦14Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦15Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖÀÔ ÆßÇÁ ¹× ¾×¼¼¼­¸® ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦16Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Moog Inc.ÀÇ CURLIN 8000Àº ÷´Ü ¾ÈÀü ±â´É°ú »ç¿ëÀÚ Ä£È­ÀûÀÎ µðÀÚÀÎÀ» °®Ãá ½Å·ÚÇÒ ¼ö ÀÖ´Â ÀçÅà ÁÖÀÔ ¿ä¹ýÀ¸·Î FDA Çã°¡¸¦ ¹Þ¾Ò½À´Ï´Ù.
    • Baxter InternationalÀÇ Dose IQ ¾ÈÀü ¼ÒÇÁÆ®¿þ¾î¸¦ žÀçÇÑ Novum IQ ÁÖÀÔ Ç÷§ÆûÀÌ FDA 510(k) Àΰ¡¸¦ Ãëµæ
    • Lemer Pax´Â ICU Medical°ú Á¦ÈÞÇÏ¿© P um 360 i Ç»Àü ÆßÇÁ¸¦ ÆÇ¸ÅÇÏ¿© ¾ÈÀü¼º°ú Á¤¹Ðµµ Çâ»ó
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Avanos Medical, Inc.
  • B. Braun SE
  • Baxter Healthcare Corporation
  • Becton, Dickinson, and Company
  • Cane SpA
  • Eitan Medical
  • Fresenius Kabi India Pvt. Ltd.
  • Freudenberg Medical
  • ICU Medical, Inc
  • Insulet Corporation
  • IRadimed Corporation
  • Medical Device Business Services, Inc.
  • Medtronic plc
  • Micrel Medical Devices SA
  • Mindray Medical India Pvt. Ltd
  • Moog Inc.
  • Narang Medical Limited
  • NIPRO CORPORATION
  • Roche Diabetes Care
  • SAI Infusion Technologies
  • Shenzhen Hawk Medical Instrument Co., Ltd
  • Tandem Diabetes Care, Inc.
  • Teleflex Incorporated
  • Terumo Europe NV
  • Universal Specialities Limited
BJH 24.11.07

The Infusion Pumps & Accessories Market was valued at USD 16.56 billion in 2023, expected to reach USD 17.83 billion in 2024, and is projected to grow at a CAGR of 7.84%, to USD 28.11 billion by 2030.

Infusion pumps and accessories are critical in the healthcare sector, used for delivering fluids, such as medications and nutrients, into a patient's body in controlled amounts. The market scope includes various types of pumps, like volumetric, syringe, and patient-controlled analgesia pumps, along with necessary accessories like tubing, catheters, and specialized IV sets. These devices are crucial in hospitals, clinics, and home healthcare settings, serving purposes such as pain management, diabetes management, and chemotherapy. The market is experiencing significant growth influenced by factors like the increasing prevalence of chronic diseases, technological advancements in medical devices, and the rising demand for home-based healthcare solutions. Furthermore, the COVID-19 pandemic underscored the necessity for reliable and versatile medical devices, fueling further market expansion. Yet, challenges such as stringent regulatory requirements, high costs of smart infusion systems, and risks of device malfunctions pose potential stumbling blocks. Opportunities lie in addressing these challenges, such as developing cost-effective, portable, and user-friendly pumps, which could not only widen the application base but also improve patient compliance and safety. Research into wireless connectivity and integration with health monitoring systems remains a strong innovation area, potentially transforming the functionality and appeal of infusion systems. Collaborating with healthcare providers to tailor solutions to end-user needs can also be a strategic move. The market's nature is highly competitive and regulated, demanding continuous innovation and adaptability. Companies can leverage data analytics to refine product offerings and focus on emerging markets, where demand might be underserved yet rapidly growing. Targeted advancements in AI and IoT applications within infusion systems can create groundbreaking solutions, thereby capturing new customer demographics and setting industry standards.

KEY MARKET STATISTICS
Base Year [2023] USD 16.56 billion
Estimated Year [2024] USD 17.83 billion
Forecast Year [2030] USD 28.11 billion
CAGR (%) 7.84%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infusion Pumps & Accessories Market

The Infusion Pumps & Accessories Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases
    • Favorable regulations and insurance coverage for infusion therapy
  • Market Restraints
    • High initial investment and maintenance costs of advanced infusion pumps
  • Market Opportunities
    • Integrating AI to improve dosing accuracy and predict maintenance requirements
    • Innovations in more biocompatible materials to reduce infection risk and improve patient safety
  • Market Challenges
    • Navigating the complex regulatory environment for medical devices can delay product launches

Porter's Five Forces: A Strategic Tool for Navigating the Infusion Pumps & Accessories Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infusion Pumps & Accessories Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infusion Pumps & Accessories Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infusion Pumps & Accessories Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infusion Pumps & Accessories Market

A detailed market share analysis in the Infusion Pumps & Accessories Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infusion Pumps & Accessories Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infusion Pumps & Accessories Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Infusion Pumps & Accessories Market

A strategic analysis of the Infusion Pumps & Accessories Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infusion Pumps & Accessories Market, highlighting leading vendors and their innovative profiles. These include Avanos Medical, Inc., B. Braun SE, Baxter Healthcare Corporation, Becton, Dickinson, and Company, Cane S.p.A., Eitan Medical, Fresenius Kabi India Pvt. Ltd., Freudenberg Medical, ICU Medical, Inc, Insulet Corporation, IRadimed Corporation, Medical Device Business Services, Inc., Medtronic plc, Micrel Medical Devices SA, Mindray Medical India Pvt. Ltd, Moog Inc., Narang Medical Limited, NIPRO CORPORATION, Roche Diabetes Care, SAI Infusion Technologies, Shenzhen Hawk Medical Instrument Co., Ltd, Tandem Diabetes Care, Inc., Teleflex Incorporated, Terumo Europe NV, and Universal Specialities Limited.

Market Segmentation & Coverage

This research report categorizes the Infusion Pumps & Accessories Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories & Consumables and Infusion Pumps. The Accessories & Consumables is further studied across Cannulas, Infusion Catheters, IV Sets, and Needleless Connectors. The Infusion Pumps is further studied across Ambulatory Infusion Pumps, Enteral Infusion Pumps, Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Syringe Infusion Pumps, and Volumetric Infusion Pumps.
  • Based on Mode of Administration, market is studied across Arterial, Epidural, Intravenous, and Subcutaneous.
  • Based on Mode, market is studied across Portable Infusion Pump and Stationary Infusion Pump.
  • Based on Operation, market is studied across Electrically Operated and Mechanically Operated.
  • Based on Application, market is studied across Analgesia/Pain Management, Chemotherapy, Diabetes Management, Gastroenterology, Hematology, and Pediatrics/Neonatology.
  • Based on End-User, market is studied across Academic & Research Institutes, Ambulatory Care Settings, Home Care, and Hospitals.
  • Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Direct Sales, Hospital Pharmacy, and Retail Pharmacy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases
      • 5.1.1.2. Favorable regulations and insurance coverage for infusion therapy
    • 5.1.2. Restraints
      • 5.1.2.1. High initial investment and maintenance costs of advanced infusion pumps
    • 5.1.3. Opportunities
      • 5.1.3.1. Integrating AI to improve dosing accuracy and predict maintenance requirements
      • 5.1.3.2. Innovations in more biocompatible materials to reduce infection risk and improve patient safety
    • 5.1.4. Challenges
      • 5.1.4.1. Navigating the complex regulatory environment for medical devices can delay product launches
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rising demand for infusion pumps to infuse fluids into a circulatory system of patient
    • 5.2.2. End-User: Increasing adoption in hospitals for high reliability and compatibility with various treatments
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Infusion Pumps & Accessories Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories & Consumables
    • 6.2.1. Cannulas
    • 6.2.2. Infusion Catheters
    • 6.2.3. IV Sets
    • 6.2.4. Needleless Connectors
  • 6.3. Infusion Pumps
    • 6.3.1. Ambulatory Infusion Pumps
    • 6.3.2. Enteral Infusion Pumps
    • 6.3.3. Implantable Infusion Pumps
    • 6.3.4. Insulin Infusion Pumps
    • 6.3.5. Patient-Controlled Analgesia Pumps
    • 6.3.6. Syringe Infusion Pumps
    • 6.3.7. Volumetric Infusion Pumps

7. Infusion Pumps & Accessories Market, by Mode of Administration

  • 7.1. Introduction
  • 7.2. Arterial
  • 7.3. Epidural
  • 7.4. Intravenous
  • 7.5. Subcutaneous

8. Infusion Pumps & Accessories Market, by Mode

  • 8.1. Introduction
  • 8.2. Portable Infusion Pump
  • 8.3. Stationary Infusion Pump

9. Infusion Pumps & Accessories Market, by Operation

  • 9.1. Introduction
  • 9.2. Electrically Operated
  • 9.3. Mechanically Operated

10. Infusion Pumps & Accessories Market, by Application

  • 10.1. Introduction
  • 10.2. Analgesia/Pain Management
  • 10.3. Chemotherapy
  • 10.4. Diabetes Management
  • 10.5. Gastroenterology
  • 10.6. Hematology
  • 10.7. Pediatrics/Neonatology

11. Infusion Pumps & Accessories Market, by End-User

  • 11.1. Introduction
  • 11.2. Academic & Research Institutes
  • 11.3. Ambulatory Care Settings
  • 11.4. Home Care
  • 11.5. Hospitals

12. Infusion Pumps & Accessories Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Offline
    • 12.2.1. Direct Sales
    • 12.2.2. Hospital Pharmacy
    • 12.2.3. Retail Pharmacy
  • 12.3. Online

13. Americas Infusion Pumps & Accessories Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Infusion Pumps & Accessories Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Infusion Pumps & Accessories Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
    • 16.3.1. Moog Inc.'s CURLIN 8000 receives FDA clearance for reliable home infusion therapy with advanced safety features and user-friendly design
    • 16.3.2. Baxter International Inc.'s Novum IQ Infusion Platform with Dose IQ Safety Software receives FDA 510(k) clearance
    • 16.3.3. Lemer Pax partners with ICU Medical to distribute P um 360 i fusion pump, enhancing safety and precision
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Avanos Medical, Inc.
  • 2. B. Braun SE
  • 3. Baxter Healthcare Corporation
  • 4. Becton, Dickinson, and Company
  • 5. Cane S.p.A.
  • 6. Eitan Medical
  • 7. Fresenius Kabi India Pvt. Ltd.
  • 8. Freudenberg Medical
  • 9. ICU Medical, Inc
  • 10. Insulet Corporation
  • 11. IRadimed Corporation
  • 12. Medical Device Business Services, Inc.
  • 13. Medtronic plc
  • 14. Micrel Medical Devices SA
  • 15. Mindray Medical India Pvt. Ltd
  • 16. Moog Inc.
  • 17. Narang Medical Limited
  • 18. NIPRO CORPORATION
  • 19. Roche Diabetes Care
  • 20. SAI Infusion Technologies
  • 21. Shenzhen Hawk Medical Instrument Co., Ltd
  • 22. Tandem Diabetes Care, Inc.
  • 23. Teleflex Incorporated
  • 24. Terumo Europe NV
  • 25. Universal Specialities Limited
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦